Marjorie Pick

4PUBLICATIONS
19CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 09, 2024
Efficacy and Safety of Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T-Cell for the Treatment of Relapsed and Refractory AL Amyloidosis.

Eyal Lebel, Nathalie Asherie, Shlomit Kfir-Erenfeld

|May 20, 2024
Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma.

Shlomit Kfir-Erenfeld, Nathalie Asherie, Eyal Lebel

|Sep 15, 2022
Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis.

Shlomit Kfir-Erenfeld, Nathalie Asherie, Sigal Grisariu

|May 28, 2022
CD24 Is a Prognostic Marker for Multiple Myeloma Progression and Survival.

Noa Gross Even-Zohar, Marjorie Pick, Liron Hofstetter

Pageof 1

Frequent Collaborators

4 joint publications

Eyal Lebel

4 joint publications

Moshe E Gatt

3 joint publications

Nathalie Asherie

3 joint publications

Cyrille J Cohen